MetLife Investment Management LLC Grows Stock Holdings in Evolv Technologies Holdings, Inc. (NASDAQ:EVLV)

MetLife Investment Management LLC boosted its stake in Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) by 7.1% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 77,055 shares of the company’s stock after purchasing an additional 5,090 shares during the period. MetLife Investment Management LLC’s holdings in Evolv Technologies were worth $312,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD raised its position in Evolv Technologies by 18.2% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 32,813 shares of the company’s stock worth $147,000 after buying an additional 5,062 shares during the last quarter. ARS Investment Partners LLC purchased a new position in Evolv Technologies during the second quarter worth about $69,000. Bank of New York Mellon Corp boosted its holdings in Evolv Technologies by 13.9% in the 2nd quarter. Bank of New York Mellon Corp now owns 443,006 shares of the company’s stock valued at $1,130,000 after purchasing an additional 54,010 shares in the last quarter. Worth Financial Advisory Group LLC boosted its holdings in Evolv Technologies by 42.0% in the 2nd quarter. Worth Financial Advisory Group LLC now owns 15,000 shares of the company’s stock valued at $38,000 after purchasing an additional 4,435 shares in the last quarter. Finally, Principal Financial Group Inc. increased its position in Evolv Technologies by 30.5% during the 2nd quarter. Principal Financial Group Inc. now owns 17,650 shares of the company’s stock worth $45,000 after purchasing an additional 4,127 shares during the period. 66.65% of the stock is owned by hedge funds and other institutional investors.

Evolv Technologies Trading Down 4.2 %

NASDAQ:EVLV opened at $4.29 on Monday. Evolv Technologies Holdings, Inc. has a twelve month low of $2.01 and a twelve month high of $5.73. The company has a market capitalization of $675.89 million, a P/E ratio of -30.64 and a beta of 1.67. The firm has a 50-day moving average price of $3.40 and a two-hundred day moving average price of $3.27.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on EVLV. TD Cowen lowered Evolv Technologies from a “strong-buy” rating to a “strong sell” rating in a report on Monday, October 28th. Northland Securities downgraded shares of Evolv Technologies from an “outperform” rating to a “market perform” rating in a report on Monday, October 28th. Lake Street Capital reduced their price objective on shares of Evolv Technologies from $3.50 to $2.75 and set a “hold” rating for the company in a research note on Monday, October 28th. Finally, Northland Capmk lowered shares of Evolv Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Evolv Technologies currently has an average rating of “Hold” and a consensus price target of $5.60.

Evolv Technologies Company Profile

Evolv Technologies Holdings, Inc provides artificial intelligence (AI)-based weapons detection for security screening in the United States and internationally. Its products include Evolv Express, a touchless security screening system designed to detect firearms, improvised explosive devices, and tactical knives; and Evolv Insights that provides self-serve access, insights regarding visitor flow and arrival curves, location specific performance, system detection performance, and alarm statistics.